Please assess the completion status of the following clinical trial:

Trial Title: Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* End-stage renal disease~* Hemodialysis~* Hypertension~* Written informed consent~Exclusion Criteria:~* Hypotension of less than 90 mmHg systolic~* High-grade aortic stenosis~* Heart failure of NYHA stage III and IV~* Acute myocardial infarction (within the last 4 weeks)~* Acute heart failure~* Known allergy to the medicament amlodipine or other constituents of the medicament~* Severe disorders of liver function~* Pregnancy and breast-feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Amlodipine
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).